Evaluation Of The Inpatients Who Apply With High INR-Level Due To Warfarine Use- A Retrospective Descriptive Study

Abstract

Objective: In this study, we searcheddemographic analysis of complications of patients who took warfarin treatment andadmitted to our hospital with high INR levels and factors affecting mortality. Material and Method: All patients who were admitted to our hospital for any reason, who had at least 4 INR and received warfarin treatment were included in the study. The studies were analyzed retrospectively. The hospitalization epicrisis of 187 patients was evaluated. Questions were asked about duration of warfarin use, follow-up frequency, primary health care status, changes in the floor made by the clinic, and the use of warfarin data. Results: The study population consisted of 87 women and 100 men. The mean age of the patients was 64.1 ± 17.6 years. The most common hospitalization complaints in the whole population were bleeding (22.4%), dyspnea (18.2%), confusion (17.1%) and nausea / vomiting (9.6%). INR level was above 10 in 34.2% of the patients. The highest indication of warfarin use was AF. Hypertension was the highest comorbidity. The predictors of mortality were chest pain (HR = 3.808; p = 0.012) and hemathesis (HR = 3.688; p = 0.033), respectively. The number of patients admitted to primary care for warfarin was 23 (12.3%). Patients were followed up in cardiology, home health care, cardiovascular surgery and neurology (16%, 6.4%, 5.9%, 4.3%, respectively). The rate of people who received warfarin training was 36.8%. Conclusion: Although warfarin is a drug that should be monitored frequently, the follow-up frequency of patients is very low.

Keywords

• kanama
• inr
• mortalite
• birinci basamak sağlık hizmetleri
• warfarin
• bleeding
• inr
• mortality
• primary health care
• warfarine